Live Price
Live Volume
Chart Volume 0
Volume 0
5 secNeuroSense Therapeutics Market Segments
Overnight
*No Trades in Segment
After Hours
+0.00(+0.00%)
| Open | $2.33 |
|---|---|
| Close | $2.33 |
| Low | $2.33 |
| Low Change | 0.00 (0.00%) |
| High | $2.33 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 135 |
| Dollar Volume | $314.55 |
Regular Trading Hours
-0.11(-4.31%)
| Open | $2.47 |
|---|---|
| Close | $2.36 |
| Low | $2.31 |
| Low Change | -0.16 (-6.34%) |
| High | $2.75 |
| High Change | +0.28 (+11.50%) |
| Range | $0.44 |
| Volume | 27.716K |
| Dollar Volume | $65.41K |
Premarket
*No Trades in Segment
After Hours Yesterday
+0.00(+0.00%)
| Open | $2.46 |
|---|---|
| Close | $2.46 |
| Low | $2.46 |
| Low Change | 0.00 (0.00%) |
| High | $2.46 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 261 |
| Dollar Volume | $642.06 |
Regular Trading Hours Yesterday
+0.06(+2.41%)
| Open | $2.49 |
|---|---|
| Close | $2.55 |
| Low | $2.40 |
| Low Change | -0.09 (-3.61%) |
| High | $2.55 |
| High Change | +0.06 (+2.41%) |
| Range | $0.15 |
| Volume | 9.428K |
| Dollar Volume | $24.04K |
Premarket Yesterday
-0.06(-2.48%)
| Open | $2.42 |
|---|---|
| Close | $2.36 |
| Low | $2.36 |
| Low Change | -0.06 (-2.48%) |
| High | $2.42 |
| High Change | +0.00 (+0.00%) |
| Range | $0.06 |
| Volume | 494 |
| Dollar Volume | $1.17K |
NeuroSense Therapeutics News
NeuroSense Therapeutics Top Trades
NeuroSense Therapeutics's top trade so far today returned +11.50%, while the top short trade returned -15.27%.
NeuroSense Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $2.47 |
|---|---|
| 10 Day Moving Average (SMA10) | $2.79 |
| 20 Day Moving Average (SMA20) | $3.41 |
| 50 Day Moving Average (SMA50) | $3.02 |
| 100 Day Moving Average (SMA100) | $1.84 |
| 200 Day Moving Average (SMA200) | $1.35 |
NeuroSense Therapeutics Statistics
| Average Volume (30 Days) | — |
|---|---|
| P/E Ratio (Current) | — |
| EPS (Current) | — |
| Dividend Yield | — |
| Free Cash Flow | — |
| Cash Ratio | — |
| Current Ratio | — |
| Quick Ratio | — |
| Debt to Equity | — |
| Enterprise Value | — |
| EV to EBITDA | — |
| EV to Sales | — |
| Price to Book | — |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | — |
| Return on Equity | — |
NeuroSense Therapeutics Stock Splits
There has been 1 stock split for NeuroSense Therapeutics (NRSN). The reverse stock split occured on September 14, 2026 and reduced the outstanding shares at a ratio of 20:1.
| Date | Type | Ratio |
|---|---|---|
| Sep 14, 2026 | Reverse | 20:1 |
NeuroSense Therapeutics Dividends
There have been no dividends for NeuroSense Therapeutics (NRSN).